Delivery Order SPE2DB22D1103-SPE2DB25FTKB7

Award Date 4/10/25
Potential Completion Date 4/11/25
Potential Value $8.6K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of 4,568,062,454 units of Diovan HCT 160-12.5 mg tablets in 90-count packages, with a ceiling value of $2,825.59. The contract has an ultimate completion date of April 29, 2025 and was awarded on April 28, 2025. This delivery order is part of a larger Indefinite Delivery...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of 4,561,082,757 units of Diovan HCT 160-12.5 mg tablets, a cardiovascular medication, for a firm fixed price of $12,979.35. The contract has a period of performance through May 31, 2023 and was awarded on May 30, 2023. This award is associated with a larger Indefinite Delivery Contract...
This is a firm fixed price delivery order awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, for the supply of 4,563,589,059 tablets of Diovan HCT 160-25 mg. The contract has a potential value of $9,096.15 and a completion date of February 8, 2024. This delivery order is part of a larger indefinite delivery contract (IDC) awarded solely to Amerisourcebergen Drug Corp, with a potential value of...
This is a firm fixed price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a subsidiary of the global pharmaceutical company AmerisourceBergen Corporation. The $25,782.97 order is for the supply of Diovan HCT 160-25 mg tablets, a prescription medication. This delivery order is placed under an indefinite delivery contract (IDC) with a potential value of $999,999,999.00 and a performance period through December 31, 2025. The IDC serves as the primary...
This is a $26,501.75 firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the provision of Diovan HCT 320-12.5 mg tablets, a cardiovascular medication, to support military healthcare programs globally. This delivery order is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA...
This is a firm-fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $17,145.30, is for the supply of Diovan HCT 320-12.5 mg tablets. The contract has no set-aside designation, indicating open competition. Amerisourcebergen Drug Corp is the prime contractor and holds a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support...
This is a $3,374.37 firm-fixed price delivery order contract awarded to Amerisourcebergen Drug Corp by the Defense Logistics Agency (DLA) Troop Support Medical on August 23, 2024. The contract is for the supply of Diovan HCT 160-25 mg tablets, a prescription medication. The award has an ultimate completion date of August 26, 2024 and is not a set-aside contract. Amerisourcebergen is a major pharmaceutical distributor that holds several Indefinite Delivery Contracts (IDCs) with federal...
This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $4,914.69, is for the delivery of Diovan HCT 80-12.5 mg tablets over a period ending on April 23, 2025. The contract is a firm fixed-price delivery order, with no set-aside designation, indicating open competition. Amerisourcebergen Drug Corp is the prime contractor and is...
This is a federal contract award from the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $2,931.27 firm fixed-price delivery order is for the supply of Diovan HCT 160-12.5 mg tablets. The contract has an ultimate completion date of June 4, 2025. Amerisourcebergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with DLA Troop Support Medical valued at $999,999,999.00. This prime contract,...
This is a federal delivery order contract awarded by the Medical Supply Chain division of the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract has a ceiling value of $31,914.40 and is for the delivery of Diovan HCT 160-25 mg tablets. The contract is a firm fixed-price delivery order with an ultimate completion date of October 23, 2023. The contract is not designated as a set-aside. AmerisourceBergen Drug Corp holds a larger...
  • SPE2DB22D1103
    Indefinite Delivery Contract
  • SPE2DB22D1103-SPE2DB25FTKB7
    Delivery Order

This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The $8,574.32 contract is for the supply of 4,567,873,866 units of Diovan HCT 160-25 mg tablets. This delivery order is part of a larger $999,999,999.00 Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA Troop Support Medical, which provides a comprehensive global pharmaceutical support vehicle with a performance period through December 2026. The contract is not set aside and is open to full and open competition. AmerisourceBergen, as the prime contractor, will deliver the pharmaceutical products to support military healthcare programs worldwide, including the Defense Health Agency and U.S. Coast Guard.

Generated 7/17/25, 6:19 PM